Using duplex DNA-AuNP aggregates, a sequence-specific DNA-binding protein, SQUAMOSA Promoter-binding-Like protein 12 (SPL-12), was directly determined by SPL-12-duplex DNA interaction-based colorimetric actions of DNA-Au assemblies. In order to prepare duplex DNA-Au aggregates, thiol-modified DNA 1 and DNA 2 were attached onto the surface of AuNPs, respectively, by the salt-aging method and then the DNA-attached AuNPs were mixed. Duplex-DNA-Au aggregates having the average size of 160 nm diameter and the maximum absorption at 529 nm were able to recognize SPL-12 and reached the equivalent state by the addition of ∼30 equivalents of SPL-12 accompanying a color change from red to blue with a red shift of the maximum absorption at 570 nm. As a result, the aggregation size grew to about 247 nm. Also, at higher temperatures of the mixture of duplex-DNA-Au aggregate solution and SPL-12, the equivalent state was reached rapidly. On the contrary, in the control experiment using Bovine Serum Albumin (BSA), no absorption band shift of duplex-DNA-Au aggregates was observed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c6an00033a | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
NR4A3 inhibits the tumor progression of hepatocellular carcinoma by inducing cell cycle G0/G1 phase arrest and upregulation of CDKN2AIP expression.
Int J Biol Sci
December 2024
State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.
Nuclear receptor subfamily 4 group A member 3 (NR4A3) is a member of the orphan nuclear receptor superfamily, and exhibits transcription factor activity by binding to sequence-specific DNA. Considering that the specific mechanism by which NR4A3 regulates gene transcription in HCC (hepatocellular carcinoma) has not yet been elucidated, our study aimed to explore the transcriptional role of NR4A3 in regulating the target gene CDKN2AIP (CDKN2A interacting protein), which will suppress the development of HCC. Our data show that NR4A3 is downregulated in human HCC tissues, and that low expression of NR4A3 is correlated with poor prognosis, indicating that NR4A3 could act as a tumor suppressor gene in HCC.
View Article and Find Full Text PDFWhole Genome Methylation Sequencing via Enzymatic Conversion (EM-seq): Protocol, Data Processing, and Analysis.
Methods Mol Biol
November 2024
Bioinformatics Group, Babraham Institute, Cambridge, UK.
Article Synopsis
- Whole genome bisulfite sequencing (WGBS) has been the main method for analyzing DNA methylation but has issues with technical biases that can lead to inaccurate results, especially in cytosine-rich areas.
- A new technique called EM-seq is emerging to replace WGBS, using a two-step enzymatic conversion process that avoids the damaging effects of bisulfite conversion.
- EM-seq offers advantages like being degradation-free, requiring less DNA, achieving higher yields, ensuring less variation, and providing accurate and uniform results across a wider range of methylation sites.
Functional characteristics and computational model of abundant hyperactive loci in the human genome.
Elife
November 2024
National Institute for Biotechnology and Information, National Library of Medicine, National Institutes of Health, Bethesda, United States.
Enhancers and promoters are classically considered to be bound by a small set of transcription factors (TFs) in a sequence-specific manner. This assumption has come under increasing skepticism as the datasets of ChIP-seq assays of TFs have expanded. In particular, high-occupancy target (HOT) loci attract hundreds of TFs with often no detectable correlation between ChIP-seq peaks and DNA-binding motif presence.
View Article and Find Full Text PDFBenchmarking and building DNA binding affinity models using allele-specific and allele-agnostic transcription factor binding data.
Genome Biol
October 2024
Department of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Background: Transcription factors (TFs) bind to DNA in a highly sequence-specific manner. This specificity manifests itself in vivo as differences in TF occupancy between the two alleles at heterozygous loci. Genome-scale assays such as ChIP-seq currently are limited in their power to detect allele-specific binding (ASB) both in terms of read coverage and representation of individual variants in the cell lines used.
View Article and Find Full Text PDFDNA flexibility regulates transcription factor binding to nucleosomes.
bioRxiv
September 2024
Division of Genetics, Department of Medicine; Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
Article Synopsis
- - Cell fate is influenced by specific transcription factors called 'pioneer' factors that can bind to target sites within nucleosomes to initiate chromatin opening, yet they only bind a small fraction of their potential binding sites in the genome.
- - Researchers developed a method called PIONEAR-seq to study how seven human pioneer TFs bind to nucleosomes, revealing that the binding preferences depend more on the local sequence context than on the properties of the TFs themselves.
- - The study suggests that the physical characteristics of nucleosomal DNA, such as its flexibility and rigidity, play a role in determining the binding locations of pioneer factors within nucleosomes, adding a new layer of regulatory information for transcription factors in eukaryotic cells.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!